
Upstream Bio Inc (UPB)
NASDAQ
The current UPB market cap is 440.56M. The company's latest EPS is USD -0.7138 and P/E is -11.45.
Quarter End | ||
---|---|---|
USD ($) | USD ($) | |
Total Revenue | ||
Operating Income | ||
Net Income |
Year End December 30 2023 | 2022 | 2023 |
---|---|---|
USD ($) | USD ($) | |
Total Revenue | 1.21M | 2.38M |
Operating Income | -23.91M | -40.11M |
Net Income | -23.87M | -38.26M |
Quarter End | ||
---|---|---|
USD ($) | USD ($) | |
Total Assets | ||
Total Liabilities | ||
Total Equity |
Year End December 30 2023 | 2022 | 2023 |
---|---|---|
USD ($) | USD ($) | |
Total Assets | 18.48M | 117.2M |
Total Liabilities | 124.63M | 240.32M |
Total Equity | -106.16M | -123.13M |
Market Cap | 440.56M |
Price to Earnings Ratio | -11.45 |
Price to Sales Ratio | 184.01 |
Price to Cash Ratio | 16.95 |
Price to Book Ratio | -3.56 |
Dividend Yield | - |
Shares Outstanding | 53.6M |
Average Volume (1 week) | 249.63k |
Average Volume (1 Month) | 228.45k |
52 Week Change | -61.77% |
52 Week High | 29.35 |
52 Week Low | 6.65 |
Spread (Intraday) | 0.15 (1.81%) |
Company Name | Upstream Bio Inc |
Address |
251 little falls drive wilmington, delaware 19808 |
Website | https://www.upstreambio.com |
Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.